Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

EDARBI DIN 02381397

Status: Marketed
Holder: BAUSCH HEALTH, CANADA INC.
Molecule: AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM)
Available to quote

Health Canada record

Active ingredient(s)AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 80 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCC09CA09 AZILSARTAN MEDOXOMIL
Original market date08-Nov-2012
Current status date13-Jul-2021
SourceHealth Canada DPD

Establishment licence of the holder

Bausch Health Companies Inc. — licence 101880, currently licensed, last inspection rating C (2026-06-01).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM)

DINProductCompanyFormStrengthStatus
02547015AURO-AZILSARTAN MEDOXOMILAURO PHARMA INCTabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 40 MGMarketed
02547023AURO-AZILSARTAN MEDOXOMILAURO PHARMA INCTabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 80 MGMarketed
02381389EDARBIBAUSCH HEALTH, CANADA INC.TabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 40 MGMarketed
02397749EDARBYCLORBAUSCH HEALTH, CANADA INC.TabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 40 MG; CHLORTHALIDONE 12.5 MGMarketed
02397765EDARBYCLORBAUSCH HEALTH, CANADA INC.TabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 40 MG; CHLORTHALIDONE 25 MGMarketed
02397757EDARBYCLORBAUSCH HEALTH, CANADA INC.TabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 80 MG; CHLORTHALIDONE 12.5 MGDormant

Notices of Compliance

NOCDateSubmissionReason
262482021-07-13New Drug Submission (NDS)Administrative: Change in Product Ownership Updates to the Product Labelling
167432015-03-25New Drug Submission (NDS)TRANSFER OF DRUG IDENTIFICATION NUMBER
130882012-03-08New Drug Submission (NDS)
Request a quote for EDARBI

How to read a Canadian DIN record